GBA1 and Parkinson disease: Due to the high prevalence of GBA mutations, roughly 10% of PD patients in Germany and 30% of the Ashkenazi Jewish population carry a GBA1-mutation, irrespective of family history—in otherwise typical late-onset PD and due to the relatively severe phenotype of GBA-associated PD, gene and mutation-specific treatments are under development.